Literature DB >> 25580448

Resolution of chronic ocular sarcoidosis with antimycobacterial therapy.

Bradley W Richmond1, Kyra Richter2, Lloyd E King3, Wonder P Drake4.   

Abstract

Ocular and cutaneous sarcoidosis is a chronic manifestation of sarcoidosis that remains difficult to treat. Recent investigations demonstrating efficacy with antimicrobial therapy in pulmonary and cutaneous sarcoidosis have been reported. Here, we report dual clinical improvement in cutaneous and ocular sarcoidosis following administration of oral antimycobacterial therapy.

Entities:  

Keywords:  Antibiotics; Ocular sarcoidosis; Sarcoidosis; T cell proliferation

Year:  2014        PMID： 25580448      PMCID： PMC4286311          DOI： 10.5430/crim.v1n2p216

Source DB:  PubMed          Journal:  Case Rep Intern Med        ISSN： 2332-7243


  18 in total

Review 1.  The treatment of pulmonary sarcoidosis.

Authors:  Marc A Judson
Journal:  Respir Med       Date:  2012-04-09       Impact factor: 3.415

2.  Oral minocycline in treatment of cutaneous sarcoidosis.

Authors:  Talora Steen; Joseph C English
Journal:  JAMA Dermatol       Date:  2013-06       Impact factor: 10.282

3.  Proliferative response of peripheral blood mononuclear cells and levels of antibody to recombinant protein from Propionibacterium acnes DNA expression library in Japanese patients with sarcoidosis.

Authors:  Y Ebe; S Ikushima; T Yamaguchi; K Kohno; A Azuma; K Sato; I Ishige; Y Usui; T Takemura; Y Eishi
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2000-10       Impact factor: 0.670

Review 4.  Ocular sarcoidosis.

Authors:  Robert P Baughman; Elyse E Lower; Adam H Kaufman
Journal:  Semin Respir Crit Care Med       Date:  2010-07-27       Impact factor: 3.119

5.  Is mycobacterial heat shock protein 16 kDa, a marker of the dormant stage of Mycobacterium tuberculosis, a sarcoid antigen?

Authors:  Anna Dubaniewicz; Adam Holownia; Leszek Kalinowski; Monika Wybieralska; Iwona T Dobrucki; Mahavir Singh
Journal:  Hum Immunol       Date:  2012-10-16       Impact factor: 2.850

6.  Management of ocular sarcoidosis.

Authors:  R P Baughman; E E Lower; R Ingledue; A H Kaufman
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2012-03       Impact factor: 0.670

7.  Oral antimycobacterial therapy in chronic cutaneous sarcoidosis: a randomized, single-masked, placebo-controlled study.

Authors:  Wonder P Drake; Kyra Oswald-Richter; Bradley W Richmond; Joan Isom; Victoria E Burke; Holly Algood; Nicole Braun; Thyneice Taylor; Kusum V Pandit; Caroline Aboud; Chang Yu; Naftali Kaminski; Alan S Boyd; Lloyd E King
Journal:  JAMA Dermatol       Date:  2013-09       Impact factor: 10.282

Review 8.  Evidence-based therapy for cutaneous sarcoidosis.

Authors:  Christy B Doherty; Ted Rosen
Journal:  Drugs       Date:  2008       Impact factor: 9.546

Review 9.  The effects of macrolides on inflammatory cells.

Authors:  Jun Tamaoki
Journal:  Chest       Date:  2004-02       Impact factor: 9.410

10.  Mycobacterial catalase-peroxidase is a tissue antigen and target of the adaptive immune response in systemic sarcoidosis.

Authors:  Zhimin Song; Lisa Marzilli; Brian M Greenlee; Edward S Chen; Richard F Silver; Frederic B Askin; Alvin S Teirstein; Ying Zhang; Robert J Cotter; David R Moller
Journal:  J Exp Med       Date:  2005-03-07       Impact factor: 14.307
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.